In this episode of #ExpertAnswers, Dr. Nataliia Beztsinna and Dr. Marten Hornsveld from Crown Bioscience answer questions from a recent webinar describing how the tumor microenvironment modulates clinical responses and how patient-derived ex vivo and engineered in vitro models can be used for pre-clinical immuno-oncology testing.

For more information or to watch the webinar, click here.